Chat with us, powered by LiveChat

On Wednesday, May 27th, 2020 at 11:00 AM Eastern Time, Join ScitoVation & IONTOX For A Joint Webinar


On Wednesday, May 27th, 2020 at 11:00 AM Eastern Standard Time, join ScitoVation, L.L.C. experts in kinetic modeling and IONTOX, L.L.C. known for in vitro toxicity testing for a 45 minute webinar describing the integrated organ platform and the use of kinetic modeling.

Register For The ScitoVation & IONTOX Joint Webinar

Click The Button Below To Register For The Webinar
Attendance limited to the first 150 registrants

Webinar Format

Webinar Overview

During the webinar James McKim, Ph.D. DABT will present first on the IONTOX HuDMOP™ integrated organ platform and data generated followed by Melvin Andersen, Ph.D., DABT who will discuss models that describe chemical behavior. Following the formal presentation there will be a 15 minute Q&A session. A recording of the live webinar will be made available to all who register prior to webinar.

Attendance is limited to the first 150 registrants.

Attendance limited to the first 150 registrants

About The Panelists

First Panelist

James (Jim) McKim, Ph.D.
James McKim, Ph.D. is the President, CEO, and Founder of IONTOX. He has over 30 years experience in biochemical and molecular toxicology and is known primarily for his work developing in vitro models to predict toxicity. In 2014, he founded IONTOX to continue building improved in vitro models for predicting toxicity.

Dr. McKim has been a Diplomat of the American Board of Toxicology since 1995, a full member of the Society of Toxicology since 1980, and has published numerous abstracts, manuscripts, and book chapters.

Attendance limited to the first 150 registrants

Second Panelist

Melvin (Mel) Andersen, Ph.D.

Melvin Andersen, Ph.D. is Senior Program Advisor at ScitoVation. He has almost 50 years experience in toxicology and risk assessment, primarily developing and applying physiologically based pharmacokinetic and biologically based pharmacodynamic (PBPK) models in quantitative safety assessments.

He has worked in the federal government, private industry and academia. In 2007, Dr. Andersen co-authored a National Research Council report, “Toxicity Testing in the 21st Century: A Vision and a Strategy,” and now works with clients to apply new alternative methods (NAMs) and toxicity pathway-based approaches outlined in this report to support chemical safety assessments.

Mel works with ScitoVation research sponsors to assess MOAs using time and dose-related changes in gene expression in cells and tissues, suggests approaches to use NAMs in human health risk assessment and continues his career-long interest in using PK models in safety assessment. Dr. Andersen has received many awards for professional contributions, including the Frank Blood (1982), Achievement (1984), Arnold J. Lehman (2004) and Merit Awards (2016) from the Society of Toxicology and the Mildred Christian Award for career achievements from the Academy of Toxicological Sciences.
He is a certified industrial hygienist, a diplomate of the American Board of Toxicology and Fellow of the Academy of Toxicological Sciences. He has a Ph.D. in biochemistry and molecular biology from Cornell University.

Attendance limited to the first 150 registrants

About HuDMOP™

HuDMOP™ Background Information

HuDMOP™ is a multiple organ culture system, which utilizes 2D and 3D tissues connected with simulated blood flow system. This system allows for human organ models to be interconnected in a way that mimics a proprietary simulated blood flow system to generate physiologically correct, human relevant data, In Vitro.

Attendance limited to the first 150 registrants